| Literature DB >> 36168602 |
Lais B Razza1,2,3, Matthias S Luethi1, Tamires Zanão1, Stefanie De Smet2,3, Carlos Buchpiguel4, Geraldo Busatto5, Juliana Pereira1, Izio Klein1, Mitchel Kappen2,3, Marina Moreno6, Chris Baeken2,3,7,8, Marie-Anne Vanderhasselt2,3,9, André R Brunoni1,5,10,6.
Abstract
Non-invasive brain stimulation (NIBS) techniques have been increasingly used over the dorsolateral prefrontal cortex (DLPFC) to enhance working memory (WM) performance. Notwithstanding, NIBS protocols have shown either small or inconclusive cognitive effects on healthy and neuropsychiatric samples. Therefore, we assessed working memory performance and safety of transcranial direct current stimulation (tDCS), intermittent theta-burst stimulation (iTBS), and both therapies combined vs placebo over the neuronavigated left DLPFC of healthy participants. Twenty-four subjects were included to randomly undergo four sessions of NIBS, once a week: tDCS alone, iTBS alone, combined protocol and placebo. The 2-back task and an adverse effect scale were applied after each NIBS session. Results revealed a significantly faster response for iTBS (b= -21.49, p= 0.04), but not for tDCS and for the interaction tDCS vs. iTBS (b= 13.67, p= 0.26 and b= 40.5, p= 0.20, respectively). No changes were observed for accuracy and no serious adverse effects were found among protocols. Although tolerable, an absence of synergistic effects for the combined protocol was seen. Nonetheless, future trials accessing different outcomes for the combined protocols, as well as studies investigating iTBS over the left DLPFC for cognition and exploring sources of variability for tDCS are encouraged.Entities:
Keywords: Combined interventions; Non-invasive brain stimulation; Prefrontal cortex; Synergistic effects; Working memory
Year: 2022 PMID: 36168602 PMCID: PMC9478927 DOI: 10.1016/j.ijchp.2022.100334
Source DB: PubMed Journal: Int J Clin Health Psychol ISSN: 1697-2600
Figure 1(A) Study Design. Structural MRI and the neuronavigation were performed alone in the first session. Afterwards, participants returned to the laboratory for four more sessions, in which different NIBS protocols were applied. TDCS and iTBS were applied concomitantly in all sessions. TDCS electrodes were applied bilaterally over the DLPFC and the iTBS coil was placed on the left DLPFC (over the anode). Baseline measures, adverse effect scale and the 2-back task were applied in all the four experimental sessions. (B) MRI-based computational modeling of tDCS and iTBS. For tDCS, we used a bilateral prefrontal montage with anode placed over the x-38, y+44, z+26 and cathode over the x+38, y+44, z+26, with a current of 2mA and electrodes size of 25cm². For iTBS, we centered the coil at the coordinates x-38, y+44, z+26 with 10mm from the scalp. Computational modeling was performed using SimNIBS (Thielscher et al., 2015).
Mean and standard deviation of reaction time and accuracy per protocol.
| Placebo | Combined Interventions | iTBS-only | tDCS-only | |
|---|---|---|---|---|
| % Accuracy | 0.85 (0.36) | 0.83 (0.38) | 0.82 (0.38) | 0.84 (0.37) |
| Reaction Time (in ms) | 638 (299) | 665 (308) | 618 (261) | 673 (323) |
iTBS: Intermittent theta-burst stimulation; tDCS: transcranial direct current stimulation.
Figure 2Working memory performance. (A) Mean Reaction time; (B) Mean Accuracy. Note: Bars represent 95% Confidence Intervals.
Main results.
| Beta | CI | t | p-value | ||
|---|---|---|---|---|---|
| Lower limit | Upper Limit | ||||
| tDCS vs. iTBS | 40.5 | -9.45 | 71.5 | 1.27 | 0.2 |
| iTBS | -21.5 | -32.1 | -10.9 | -1.97 | |
| tDCS | 13.7 | -1.8 | 25.5 | 1.1 | 0.26 |
| tDCS vs. iTBS | 0.18 | 0.1 | 0.46 | 0.62 | 0.53 |
| iTBS | -0.38 | -0.58 | -0.17 | -1.81 | 0.06 |
| tDCS | -0.28 | -0.5 | -0.1 | -1.26 | 0.2 |
CI: Confidence interval (95%); iTBS: Intermittent theta-burst stimulation; tDCS: transcranial direct current stimulation.
Figure 3Influence of session on the (A) reaction time and (B) accuracy performance. Note: Bars represent 95% Confidence Intervals based on 1000 bootstrap samples.
Frequency of the adverse effects in each group.
| Adverse Effects | Placebo (Sessions= 23) | Combined Interventions (Sessions = 23) | iTBS-only (Sessions = 23) | tDCS-only (Sessions = 24) | |
|---|---|---|---|---|---|
| Headache | 0 (0%) | 13 (10.9%) | 10 (8.7%) | 0 (0%) | |
| Neck Pain | 2 (1.7%) | 0 (0%) | 3 (2.6%) | 4 (3.3%) | 0.75 |
| Local Pain | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - |
| Itching | 29 (25.2%) | 31 (25.8%) | 28 (24.3%) | 31 (25.8%) | 0.99 |
| Tingling | 29 (25.2%) | 31 (25.8%) | 28 (24.3%) | 31 (25.8%) | 0.99 |
| Burning | 2 (1.7%) | 8 (6.7%) | 2 (1.7%) | 6 (5.2%) | 0.47 |
| Skin Redness | 23 (20%) | 42 (35%) | 20 (17.4%) | 45 (37.5%) | |
| Somnolence | 16 (13.9%) | 12 (10%) | 10 (8.7%) | 25 (20.8%) | 0.24 |
| Cognition Changes | 3 (2.6%) | 2 (1.7%) | 0 (0%) | 4 (3.3%) | 0.75 |
| Mood Changes | 3 (2.6%) | 5 (4.2%) | 3 (2.6%) | 6 (5.2%) | 0.92 |
| Fatigue | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - |
| Nausea | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - |
| Facial Contraction | 8 (6.9%) | 23 (19.2%) | 29 (25.2%) | 6 (5.2%) | |
| Dizziness | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | - |
iTBS: Intermittent theta-burst stimulation; tDCS: transcranial direct current stimulation.